ManuPharma 2019

We focused on building an invitation list of the most senior-level manufacturing professionals from the world’s largest pharmaceutical and biotech companies.

Spotlight


OTHER PAST CONFERENCES

AI x PHARMA x HEALTH 2024

March 27, 2024 | Finland

Welcome to learn about artificial intelligence (AI) and its transformative impact on the pharmaceutical industry and healthcare at AI x PHARMA x HEALTH 2024!

2024 AAPS NATIONAL BIOTECHNOLOGY CONFERENCE

May 13-16, 2024 | USA

The 2024 AAPS National Biotechnology Conference, scheduled for May 13-16, 2024, at the Hilton San Francisco Union Square in California, is set to be a pivotal event in the field of biotechnology. This conference aims to bring together experts and researchers to discuss and explore the latest advancements in biotechnology, focusing on the discovery, formulation, and delivery of new modalities. The event is structured around two main tracks, each encompassing multiple themes that address the forefront of biotechnological research and development. Track 1 delves into the advances in discovery, formulation, and delivery of new modalities, particularly in the biologics market. It invites submissions on a wide range of topics, including multi-specific antibodies, oligonucleotides, proteins, nanobodies, genes, RNA, peptides, cell-free manufactured proteins, vaccines, and various types of cells. The track emphasizes the importance of innovative strategies in addressing unmet medical needs through these modalities. The conference also features a second track focusing on novel strategies to advance biotherapeutic development, with themes that cover a broad spectrum of current biotechnological challenges and innovations. This includes preformulation and formulation approaches for biologics, drug delivery systems for new modalities and therapies, and the transformative role of AI/ML in drug discovery and development. Additionally, the conference will address the development strategies for novel targeted therapeutic delivery, advances in analytical and bioanalytical platform technology, and high content bioanalysis. These discussions are expected to cover cutting-edge topics such as targeted drug delivery systems, analytical platform technologies, and the integration of artificial intelligence and machine learning in drug development. Overall, the 2024 AAPS National Biotechnology Conference represents a significant gathering for the biotechnology community, offering a platform for the exchange of ideas and fostering collaborations in the pursuit of advancing biotechnological research and applications.

Pharma Contract Manufacturing Conference Europe

April 9-11, 2024 | Germany

Welcome To The Industry’s Leading Pharma Contract Manufacturing Event. Pharma Contract Manufacturing is the only event to focus specifically on how to improve CMO selection and partnering. We appreciate the critical role these play in delivering success for both patients and the organisation-at-large. We also appreciate that the bedrock of these relationships is collaboration from both sides, which is why we bring together leading pharmaceutical companies and CMOs to benchmark best practice in this area. Selecting the right CMO partner is the critical decision in getting high-quality products to patients. If this relationship fails, we fail. Our companies and patients can’t afford for us to get this decision wrong. That’s why Pharma IQ is bringing together partners from across the industry to collaborate on how we make these relationships work both now and in the future. Because for the patient to succeed, we need to succeed.

Pharma 2024

April 16-18, 2024 | Spain

The world’s leading cross-functional event for pharma changemakers Pharma’s role within the healthcare system is weakening. Increased demand, economic strains, suffocating regulatory change and a widening access gap is impacting future pipelines and commercial innovations reaching patients. Siloed functions too often compete with each other instead of complement each other, failing to rally behind a common purpose. Internal forces need to come together to secure a future where better medicines support a value proposition that resonates with our patients, payers, policy makers, HTAs and customers. No one function can do this alone, we must act as one. That’s why over 1,200 of the world's leading pharma changemakers from commercial, marketing, medical affairs, patient engagement, market access, RWE, and digital health are gathering under one roof in Barcelona at Reuters Events: Pharma 2024. We will draw up a new blueprint to bridge and align internal workforces while rewriting pharma’s value proposition, cementing its role as an integral pillar of the healthcare system. At this event, together, we will become the trusted source for scientific information, transform digital potential into meaningful patient outcomes, adapt to the incoming JCA legislation and harness growing data sources that will deliver value to customers and growing patient population needs.